Lichen Sclerosus Treatment Market Competitive Analysis to 2025: Pfizer, AstraZeneca, Valeant Pharmaceuticals, Sanofi, Sanofi Genzyme, GSK, Johnson & Johnson, and Bristol-Myers Squibb

The Lichen Sclerosus Treatment Market Report deliver comprehensive analysis of the market structure along with forecast of the various segments and sub-segments of the Lichen Sclerosus Treatment market. The report is generated based on the market type, size of the organization, availability on-premises and the end-users’ organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. The report discusses all the market trends and analyses all the impact of Buyers, Substitutes, New entrants, Competitors, and Suppliers on the market.

Lichen sclerosus (LS) is a skin disease of unknown cause, commonly appearing as whitish patches on the genitals, which can affect any body part of any person but has a strong preference for the genitals (penis, vulva) and is also known as balanitis xerotica obliterans (BXO) when it affects the penis. Lichen sclerosus is not contagious. There is a well-documented increase of skin cancer risk in LS, potentially improvable with treatment.

Some Of the Key Players in Lichen Sclerosus Treatment Market Include:

· Pfizer

· AstraZeneca

· Valeant Pharmaceuticals

· Sanofi

· Sanofi Genzyme

· GSK

· Johnson & Johnson

· Johnson & Johnson Vision

· Johnson & Johnson Health and Wellness Solutions, Inc.

· Bristol-Myers Squibb

· Acerta Pharma B.V. (A member of the AstraZeneca Group)

· Valeant Farmacêutica do Brasil

Request Sample Copy of the Report @ https://www.researchformarkets.com/sample/global-lichen-sclerosus-treatment-market-164546

Topically applied corticosteroids to the LS-affected skin are the first-line treatment for lichen sclerosus in women and men, with strong evidence showing that they are "safe and effective" when appropriately applied, even over long courses of treatment, rarely causing serious adverse effects. They improve or suppress all symptoms for some time, which highly varies across patients, until it is required to use them again. Methylprednisolone aceponate has been used as a safe and effective corticosteroid for mild and moderate cases. For severe cases, it has been theorized that mometasone furoate might be safer and more effective than clobetasol.

This report focuses on the global Lichen Sclerosus Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lichen Sclerosus Treatment development in United States, Europe and China.

Market by Type: Lichen Sclerosus Treatment Market

· Drug Therapy

· Surgery

Market by Application: Lichen Sclerosus Treatment Market

· Hospitals & Clinics

· Dermatology Clinics

· Pharmacies

· Others

Request for Report Brochure for Latest Industry Insights @ https://www.researchformarkets.com/reports/global-lichen-sclerosus-treatment-market-164546

Major Table of Contents: Lichen Sclerosus Treatment Market

1 Report Overview

2 Global Growth Trends

3 Market Share by Key Players

4 Breakdown Data by Type and Application

5 United States

6 Europe

7 China

8 Japan

9 Southeast Asia

10 India

11 Central & South America

12 International Players Profiles

13 Market Forecast 2018-2025

14 Analyst's Viewpoints/Conclusions

15 Appendix

Inquire More or Share Questions if any before the Purchase on This Report @ https://www.researchformarkets.com/inquiry/global-lichen-sclerosus-treatment-market-164546

Features mentioned in the report

1. Changing market dynamics of the industry

2. To get a comprehensive overview of the Lichen Sclerosus Treatment market.

3. Historical, current and projected market size in terms of volume and value

4. In-depth market segmentation

5. Competitive landscape

Note: Any special requirements about this report, please let us know and we can provide custom report.

About Research for Markets:

Research for Markets indulges in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East and Africa.

Contact:

Mr. A Naidu

Research for Markets

Tel: +44 8000-4182-37 (UK)

Email: alan.naidu@researchformarkets.com

This release was published on openPR.